Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DJ Orthopedics Plans $150 MiI. IPO To Fund Ro+Ten Purchase, Repay Debt

This article was originally published in The Gray Sheet

Executive Summary

A portion of DJ Orthopedics' planned $150 mil. initial public offering will be used to complete the acquisition of Italian soft orthopedic goods maker Ro+Ten SRL and its Swiss supplier Orthoservice, as part of a strategy to increase the firm's international presence.

You may also be interested in...



Encore Takes Chattanooga Express, Repeats Orthopedic Purchasing Move

Encore Medical's annual sales are expected to surpass $100 mil. following the purchase of privately held orthopedic rehabilitation equipment maker Chattanooga Group

Encore Takes Chattanooga Express, Repeats Orthopedic Purchasing Move

Encore Medical's annual sales are expected to surpass $100 mil. following the purchase of privately held orthopedic rehabilitation equipment maker Chattanooga Group

Financings In Brief

Hologic: Planned secondary offering of up to 3 mil. shares of common stock will be used in part to fund continued development of the firm's second-generation, full-field digital mammography system using DirectRay direct-to-digital technology, the firm says Nov. 19 ("1The Gray Sheet" Nov. 5, 2001, p. 24). A PMA supplement filing is anticipated in the first quarter of 2002. A portion of the net proceeds also will be used to pursue approval, as well as for R&D and general corporate purposes, the firm says. Needham & Company is acting as underwriter for the offering. Separately, the firm plans to eliminate about 80 employees and take a roughly $1 mil. restructuring charge in the first quarter of fiscal 2002 (ending Dec. 29) related to closure of a manufacturing facility in Littleton, Massachusetts and relocation of certain operations to its headquarters facility in Bedford. The move is in line with a previously announced plan to phase-out non-core and unprofitable product lines such as conventional radiographic systems...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel